Publications – LDS – Lyotropic Delivery System

Media

First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)

March 28, 2023

ANANDA Scientific in collaboration with NYU, Grossman School of Medicine

First Patient Enrolment in the FDA Approved Clinical Trial, Utilizing LDS’ Liquid Structure™ Delivery Technology, for the Treatment of Post-Traumatic Stress Disorder (PTSD)

March 16, 2023

ANANDA Scientific in collaboration with University of Nebraska Medical Center

Patient Interview Parting in a Compassionate Trail of a Novel Orphan Drug Using LDS Delivery Technology

January 5, 2023

FDA IND Approval for a Clinical Trial Utilizing LDS’ Liquid Structure™ Delivery Technology for Treatment of Social Anxiety Disorder (SAD)

December 6, 2022

ANANDA Scientific in collaboration with NYU Grossman School of Medicine

First Patient Enrolment in the Clinical Trial Utilizing LDS’ Liquid Structure™ Delivery Technology for the Treatment of Opioid Use Disorder (OUD)

July 26, 2022

ANANDA Scientific in collaboration with The David Geffen School of Medicine, UCLA

FDA IND Approval for the Clinical Trail Utilizing LDS’ Liquid Structure™ Delivery Technology for Treatment of Post-Traumatic Stress Disorder (PTSD)

May 17, 2022

ANANDA Scientific in collaboration with The University of Nebraska Medical Center

First Patient Enrolment in the Clinical Trial Utilizing LDS’ Liquid Structure™ Delivery Technology for Evaluating the Effect on Opioid Sparing in Participants with Chronic Radiculopathic Pain Syndromes

March 8, 2022

ANANDA Scientific in collaboration with NYU Grossman School of Medicine

Game Changer: Unique and Novel Nano Transport and Delivery Vehicles for Improved & Better Controlled Drug Activity

March 7, 2022

Lyotropic Delivery Systems (LDS) has developed a unique nanotechnology, in order to improve the transport and to enhance the efficiency

יכולת הובלה ייחודית בטכנולוגיית ננו חדשנית לפעילות משופרת ומבוקרת של תרופות

February 2, 2022

חברת ליוטרופיק דליברי סיסטמס פיתחה ננו-טכנולוגיה ייחודית במטרה לשפר את ההובלה ולייעל את האפקטיביות של החומר הפעיל בתרופות ותכשירים רפואיים